SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
AMAG PHARMACEUTICALS
(NQNM:AMAG Last Sale: 7.91 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (AMAG : $7.91)
$271,046 million Market Cap at Market Close, July 1, 2022
Employs 225.
Medical Products SubIndustry up .00% / Health Industry up .00% Today
100 Hayden Avenue Research Report Earnings Snapshot - Last 10/30/18
Lexington, MA 02421 Fact Sheet
Phone: (617) 498-3300 Financial Statements
Peer Comparison
Annual Reports

Brian J. G. Pereira, Pres./CEO, Edward C. English, CFO
Manufactures contrast agents and other compounds used for Magnetic Resonance Imaging. Negative FDA decision March 3, 2005. Transfer to Nasdaq from Amex June 26, 2006. February 2011, reported that Health Canada had stalled a new drug submission from AMAG with a notice of non-compliance for its Feraheme injection, intended to treat iron deficiency anemia in adult chronic kidney disease patients. Founded in 1981.
Historical Charts    Technical Analysis
No Historical Data available for AMAG

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common AMAG $7.91 $7.91 0 .0 $7.41 $8 588,933 $7.41 $8 34,266,256
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $271,046,085

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
26-JUN-06 AVM Symbol Changed to AMAG

A203
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex